A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency

Clinical trial NCT02173821 · COMPLETED

Trial details

NCT number: NCT02173821
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Growth Hormone Deficiency

Start date: 2014-10-01
Primary completion: 2015-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.